Virtual High Throughput Screening For Avian
Influenza (H5nl) Neuraminidase Inhibitors

QR Code

Virtual High Throughput Screening For Avian Influenza (H5nl) Neuraminidase Inhibitors

H5NI adalah satu daripada sub-jenis Vlrus influenza yang boleh menyebabkan ancaman pandemik bukan sahaja kepada burung, tetapi juga kepada kebanyakan spesis lain termasuk manusia Avian influenza H5NI virus which caused virulent influenza in birds is a pandemic threat causing viral disease in m...

Full description

Bibliographic Details
Main Author:	Ismail, Nurul Izza
Format:	Thesis
Language:	English
Published:	2011
Subjects:	R5-920 Medicine (General)
Online Access:	http://eprints.usm.my/29771/ http://eprints.usm.my/29771/1/VIRTUAL_HIGH_THROUGHPUT_SCREENING_FOR_AVIAN_INFLUENZA_%28H5N1%29_NEURAMINIDASE_INHIBITORS.pdf

Similar Items

Heterologous Expression Of Avian Influenza A (H5n1) Neuraminidase In Kluyveromyces Lactis And Escherichia Coli
by: Taufik, Noor Zafiah
Published: (2016)

Neuraminidase inhibitors for influenza complications: authors' reply
by: Nguyen-Van-Tam, Jonathan S., et al.
Published: (2014)

Identification Of Potential Neuraminidase Inhibitors Using Ensemble-Based Virtual Screening
by: Lim, Kok Keong
Published: (2013)

Potential Neuraminidase Inhibitors Via Virtual Screening, Kinetic Studies, And Adme Predictions
by: Nuwarda, Rina Fajri
Published: (2015)

Evaluation of hemagglutinin, neuraminidase and matrix genes of Malaysian low pathogenic avian influenza virus strain H5N2 through comprehensive sequence analysis
by: Ahmad Rizal, Nurul Fatin Shafikah
Published: (2022)

A virtual screening approach for identifying plants with anti H5N1 neuraminidase activity
by: Khairul Ikram, Nur Kusaira, et al.
Published: (2015)

High Throughput Virtual Screening For Inhibitors Of Salmonella typhi’s Dalanine- D-Alanine Ligase A
by: Tan, Chen Shen
Published: (2015)

Production, characterization and scaling up of monoclonal antibodies against neuraminidase glycoprotein of avian influenza virus subtype H9N2
by: Abdelaziz Fadul, Sana Awad
Published: (2011)

A high-throughput screen to identify novel calcineurin inhibitors
by: Margassery, L., et al.
Published: (2012)

Identification of usnic acid derivatives as new antiviral agents via virtual screening on dengue, influenza A and avian influenza A
by: Miah, Roney
Published: (2022)

Toward a unified nomenclature system for highly pathogenic avian influenza virus (H5N1)
by: Donis, R., et al.
Published: (2008)

Molecular cloning of full-length haemagglutinin (H5HA) gene of highly pathogenic avian influenza virus (HPAI) H5N1
by: Abubakar, Mustapha Bala, et al.
Published: (2009)

Expression and purification of hemagglutinin and neuraminidase recombinant protein of avian influenza a virus using immobilised metal affinity chromatography (imac)
by: Chiang, Goh Wei
Published: (2016)

Knowledge, attitude and practice and perception on the transmission of influenza A (HlNl) epidemic in different communities
by: Norsa'adah, Bachok
Published: (2012)

Impact of neuraminidase inhibitor treatment on hospitalisation in patients with pandemic influenza: a multi-method modelling approach
by: Venkatesan, Sudhir
Published: (2019)

Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09‐related pneumonia: an individual participant data meta‐analysis
by: Muthuri, Stella G., et al.
Published: (2016)

Neuraminidase inhibitors: who, when, where?
by: Nguyen-Van-Tam, Jonathan S., et al.
Published: (2015)

Purification and immunogenicity of hemagglutinin from highly pathogenic avian influenza virus H5N1 expressed in Nicotiana benthamiana
by: Pua, Teen-Lee, et al.
Published: (2017)

Determination of avian influenza virus H5N2 infection in chicken innate immune cells
by: Mohd Zaini, Farhana, et al.
Published: (2013)

Detection of avian influenza virus.
by: Omar, Abdul Rahman, et al.
Published: (2006)

The contribution of PA-X to the virulence of pandemic 2009 H1N1 and highly pathogenic H5N1 avian influenza viruses
by: Gao, Huijie, et al.
Published: (2015)

Detection of H5, H7 and H9 subtypes of avian influenza viruses by multiplex reverse transcription-polymerase chain reaction.
by: B., Chaharaein, et al.
Published: (2009)

Cellular transcripts regulated during infectinos with highly pathogenic H5N1 avian influenza virus in 3 host systems.
by: Balasubramanian, Vinod R.M.T, et al.
Published: (2011)

Use of neuraminidase inhibitors for rapid containment of influenza: a systematic review and meta-analysis of individual and household transmission studies
by: Okoli, G.N., et al.
Published: (2014)

Modelling And Syntheses Of Vanillin Derivatives Targeting Influenza Virus Neuraminidase
by: Asaruddin, Mohd Razip
Published: (2016)

Expression, Purification And Quantitation Of Hemagglutinin-Neuraminidase For Dose-Ranging Assessment Of A Recombinant Protein-Based Newcastle Disease Subunit Vaccine
by: Lye, Ping Ying
Published: (2020)

Temporal scaling behavior of avian influenza a (H5N1): The multifractal detrended fluctuation analysis
by: Leung, Yee-Hong, et al.
Published: (2011)

Impact of outpatient neuraminidase inhibitor treatment in patients infected with influenza A(H1N1)pdm09 at high risk of hospitalization: an Individual Participant Data (IPD) meta-analysis
by: Venkatesan, Sudhir, et al.
Published: (2017)

Evaluation Of Toxicity, Pharmacokinetic And Clastogenicity Profile Of Ethyl 2-[4[(Piperidin-1-yl) Phenyl]-1h-benzimidazole-5-carboxylate (Bzd9l1), Novel Sirtuin Inhibitor
by: Lee, Yeuan Ting
Published: (2022)

Clinicians' attitude towards a placebo-controlled randomised clinical trial investigating the effect of neuraminidase inhibitors in adults hospitalised with influenza
by: Bradbury, Naomi, et al.
Published: (2018)

Interaction of recombinant Gallus gallus SEPT5 and brain proteins of H5N1-avian influenza virus-infected chickens
by: Khairat, Jasmine Elanie, et al.
Published: (2017)

In silico homology modelling and identification of Tousled-like kinase 1 inhibitors for glioblastoma therapy via high throughput virtual screening protein-ligand docking
by: Kamariah Ibrahim,, et al.
Published: (2018)

Rational Design And Synthesis Of Inhibitors For H1n1 Neuraminidase And Dengue Protease Enzymes
by: Hariono, Maywan
Published: (2015)

Development of avian influenza virus H5 DNA vaccine and MDP-1 gene of Mycobacterium bovis as genetic adjuvant.
by: Jalilian, Babak, et al.
Published: (2010)

Sequence analysis of the Malaysian low pathogenic avian influenza virus strain H5N2 from duck
by: Ahmad Rizal, Fatin, et al.
Published: (2023)

Moderately-high humoral antibody responses to a H5N2 inactivated vaccine did not suppress shedding of highly pathogenic H5N1 Avian Influenza virus during challenge
by: Syed Hassan, Sharifah, et al.
Published: (2013)

Potency and efficacy of a low pathogenic H5N2 inactivated vaccine against challenge with a Malaysian H5N1 highly pathogenic avian influenza virus
by: Syed Hassan, Sharifah, et al.
Published: (2013)

In silico study of carvone derivatives as potential neuraminidase inhibitors
by: Jusoh, Noorakmar, et al.
Published: (2018)

Pharmacophore-based molecular docking and in-silico study of novel usnic acid derivatives as avian influenza A (H7N9) inhibitor
by: Roney, Miah, et al.
Published: (2022)

NL scoring technique for the assessment of learners' understanding
by: Lajis, Adidah, et al.
Published: (2010)